SARGRAMOSTIM belongs to the class of medications called colony-stimulating factors used to treat neutropenia, a deficiency of specific white blood cells caused by cancer, bone marrow transplant, chemotherapy, or other diseases. SARGRAMOSTIM helps reduce the chance of infection in cancer patients and those receiving chemotherapy medicines. Neutropenia is a condition in which the quantity of neutrophils (white blood cells) in the blood is reduced.
SARGRAMOSTIM contains Sargramostim, a growth factor that stimulates the formation of white blood cells and helps reduce the chances of infection in cancer patients receiving chemotherapy.
A healthcare professional will administer SARGRAMOSTIM. Sometimes, you may experience injection site responses such as pain, redness, or swelling. You may also experience nausea, vomiting, headache, diarrhoea, stomach pain, mouth sores, loss of appetite, hair loss and bone, joint, or muscle pain. Most of these side effects do not necessitate medical treatment and will gradually fade over time. However, if you suffer these side effects regularly, you should consult your doctor.
It is not suggested to use SARGRAMOSTIM in those who have had severe allergic responses, including anaphylaxis, to human granulocyte-macrophage colony-stimulating factor, yeast-derived products, or any component of SARGRAMOSTIM. To rule out any negative effects, keep your doctor informed about your medical condition and all medications you take. Inform your doctor if you are pregnant, intend to become pregnant, or are currently breastfeeding. Contact your doctor if you become pregnant while using SARGRAMOSTIM.
Neutropenia
SARGRAMOSTIM contains 'Sargramostim,' which is a growth factor. It belongs to the cytokine family of proteins and is extremely similar to a natural protein (granulocyte-colony stimulating factor) produced by the body. SARGRAMOSTIM acts by encouraging the bone marrow to generate more white blood cells, aiding infection resistance. SARGRAMOSTIM is used to boost white blood cell count following cancer treatment or chemotherapy, bone marrow transplantation, severe persistent neutropenia, neutropenia in HIV patients, and before stem cell donation.
Extreme caution and special care should be taken while using SARGRAMOSTIM in patients with heart disorders, liver or renal dysfunction, leukocytosis (elevated white blood cell count), myeloproliferative disorder (blood cancers), pulmonary impairment, asphyxia (a condition of deficient supply of oxygen) and prematurity or underweight in infancy and respiratory symptoms. So, keep your doctor informed about your medical condition and all the medicines you are taking to rule out any side effects.
Drug-Drug Interactions: SARGRAMOSTIM may have interaction with medicines used for the treatment of beta-thalassemia (e.g. betibeglogene autotemcel)
Drug-Food Interactions: Limit or quit the consumption of alcohol.
Drug-Disease Interactions: SARGRAMOSTIM may cause interactions with disease conditions such as arrhythmia (an irregular heartbeat), congestive heart failure, liver or renal dysfunction, leukocytosis (elevated white blood cell count), myeloproliferative disorder (blood cancers caused by changes in the stem cells inside bone marrow), prematurity/underweight in infancy and respiratory symptoms.
It is unknown whether consuming alcohol with SARGRAMOSTIM is safe. However, as a precaution, it is best to avoid or limit alcohol consumption.
It is not known if SARGRAMOSTIM will harm your unborn baby. So, inform your doctor if you are pregnant or planning to become pregnant; your doctor will prescribe only if the benefits outweigh the risks.
Your doctor may advise you to discontinue the medicine or breastfeeding based on your medical condition.
The ability to drive or utilize machines is unaffected by SARGRAMOSTIM. However, do not drive or operate machinery if you feel sleepy or dizzy after taking your medicine.
Caution should be exercised while using SARGRAMOSTIM in patients with hepatic dysfunction. Monitoring of patients with hepatic dysfunction is recommended.
Caution should be exercised while using SARGRAMOSTIM in patients with renal dysfunction. Monitoring of patients with renal dysfunction is recommended.
Your doctor will prescribe only if the benefits outweigh the risks.
Neutropenia: Neutropenia is characterized as a lower than the normal number of neutrophils (a type of white blood cell). White blood cells protect the body from infections. Without enough neutrophils, the body cannot fight bacteria, increasing the risk of many illnesses. Neutropenia can be caused by various conditions, including cancers like leukaemia, cancer treatment like radiotherapy, and infections like HIV or hepatitis.